Stock ADVENT ADVENT PHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Advent Pharma Ltd.

Equities

ADVENT

BD0492ADVPL9

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 03:30:00 30/06/2024 am IST 		5-day change 1st Jan Change
25.6 BDT -1.16% Intraday chart for Advent Pharma Ltd. -1.92% +2.81%
29/04 Advent Pharma Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
06/02 Advent Pharma Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 2,346 2,543 1,893 2,274 2,338 2,459
Enterprise Value (EV) 1 2,211 2,489 1,895 2,291 2,397 2,529
P/E ratio 21.5 x 16.1 x 16.2 x 20 x 24 x 24.9 x
Yield 0.58% 0.59% - 0.8% 0.8% 0.76%
Capitalization / Revenue 5.92 x 4.22 x 3.54 x 4.59 x 4.41 x 4.41 x
EV / Revenue 5.58 x 4.13 x 3.55 x 4.63 x 4.52 x 4.53 x
EV / EBITDA 18.2 x 10.5 x 10.1 x 13.8 x 13.7 x 13 x
EV / FCF -29.7 x -20.4 x -18.3 x -37.1 x -35.1 x -57.4 x
FCF Yield -3.37% -4.91% -5.46% -2.69% -2.85% -1.74%
Price to Book 2.68 x 2.5 x 1.69 x 1.84 x 1.78 x 1.76 x
Nbr of stocks (in thousands) 93,133 93,133 93,133 93,133 93,133 93,133
Reference price 2 25.19 27.31 20.32 24.41 25.10 26.40
Announcement Date 18/10/18 24/11/19 28/10/20 06/12/21 04/12/22 04/01/24
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 396 602 534 495.1 530.5 558
EBITDA 1 121.5 237.1 188.5 166.1 175 194
EBIT 1 97.33 212.4 155.4 127.9 133.3 135.4
Operating Margin 24.57% 35.29% 29.1% 25.84% 25.13% 24.26%
Earnings before Tax (EBT) 1 94.61 212 161.5 134.2 130.3 128.6
Net income 1 86.88 158.4 117.1 113.6 97.53 98.64
Net margin 21.94% 26.31% 21.92% 22.94% 18.39% 17.68%
EPS 2 1.171 1.701 1.257 1.220 1.047 1.059
Free Cash Flow 1 -74.5 -122.1 -103.5 -61.67 -68.27 -44.03
FCF margin -18.81% -20.29% -19.37% -12.46% -12.87% -7.89%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.1473 0.1621 - 0.1961 0.2000 0.2000
Announcement Date 18/10/18 24/11/19 28/10/20 06/12/21 04/12/22 04/01/24
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - 2.59 17.2 59.6 70.5
Net Cash position 1 135 54.5 - - - -
Leverage (Debt/EBITDA) - - 0.0137 x 0.1037 x 0.3406 x 0.3636 x
Free Cash Flow 1 -74.5 -122 -103 -61.7 -68.3 -44
ROE (net income / shareholders' equity) 11.7% 16.7% 10.9% 9.65% 7.66% 7.27%
ROA (Net income/ Total Assets) 6.99% 12% 7.53% 5.53% 5.27% 4.93%
Assets 1 1,243 1,325 1,554 2,054 1,852 2,001
Book Value Per Share 2 9.380 10.90 12.00 13.30 14.10 15.00
Cash Flow per Share 2 2.000 0.9500 0.0700 0.0300 0.0500 0.0100
Capex 1 147 273 212 184 191 203
Capex / Sales 37.08% 45.4% 39.78% 37.18% 36.03% 36.33%
Announcement Date 18/10/18 24/11/19 28/10/20 06/12/21 04/12/22 04/01/24
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Veterinary Drugs

1st Jan change Capi.
ADVENT PHARMA LTD. Stock Advent Pharma Ltd.
+2.81% 20.53M
ZOETIS INC. Stock Zoetis Inc.
-12.16% 79.1B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
-3.15% 7.13B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+21.25% 3.58B
VIRBAC Stock Virbac
-9.18% 2.93B
VIMIAN GROUP AB Stock Vimian Group AB
+16.05% 1.69B
VETOQUINOL SA Stock Vetoquinol SA
-8.50% 1.19B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-33.05% 1.11B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-36.85% 1.05B
SWEDENCARE AB Stock Swedencare AB
-3.22% 884M
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. ADVENT Stock
  4. Financials Advent Pharma Ltd.